Cargando…
How should performance in EBUS mediastinal staging in lung cancer be measured?
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061900/ https://www.ncbi.nlm.nih.gov/pubmed/27552438 http://dx.doi.org/10.1038/bjc.2016.253 |
_version_ | 1782459665901158400 |
---|---|
author | Evison, Matthew Crosbie, Philip Navani, Neal Callister, Matthew Rintoul, Robert C Baldwin, David Booton, Richard |
author_facet | Evison, Matthew Crosbie, Philip Navani, Neal Callister, Matthew Rintoul, Robert C Baldwin, David Booton, Richard |
author_sort | Evison, Matthew |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5061900 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-50619002017-10-11 How should performance in EBUS mediastinal staging in lung cancer be measured? Evison, Matthew Crosbie, Philip Navani, Neal Callister, Matthew Rintoul, Robert C Baldwin, David Booton, Richard Br J Cancer Letter to the Editor Nature Publishing Group 2016-10-11 2016-08-23 /pmc/articles/PMC5061900/ /pubmed/27552438 http://dx.doi.org/10.1038/bjc.2016.253 Text en Copyright © 2016 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ |
spellingShingle | Letter to the Editor Evison, Matthew Crosbie, Philip Navani, Neal Callister, Matthew Rintoul, Robert C Baldwin, David Booton, Richard How should performance in EBUS mediastinal staging in lung cancer be measured? |
title | How should performance in EBUS mediastinal staging in lung cancer be measured? |
title_full | How should performance in EBUS mediastinal staging in lung cancer be measured? |
title_fullStr | How should performance in EBUS mediastinal staging in lung cancer be measured? |
title_full_unstemmed | How should performance in EBUS mediastinal staging in lung cancer be measured? |
title_short | How should performance in EBUS mediastinal staging in lung cancer be measured? |
title_sort | how should performance in ebus mediastinal staging in lung cancer be measured? |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061900/ https://www.ncbi.nlm.nih.gov/pubmed/27552438 http://dx.doi.org/10.1038/bjc.2016.253 |
work_keys_str_mv | AT evisonmatthew howshouldperformanceinebusmediastinalstaginginlungcancerbemeasured AT crosbiephilip howshouldperformanceinebusmediastinalstaginginlungcancerbemeasured AT navanineal howshouldperformanceinebusmediastinalstaginginlungcancerbemeasured AT callistermatthew howshouldperformanceinebusmediastinalstaginginlungcancerbemeasured AT rintoulrobertc howshouldperformanceinebusmediastinalstaginginlungcancerbemeasured AT baldwindavid howshouldperformanceinebusmediastinalstaginginlungcancerbemeasured AT bootonrichard howshouldperformanceinebusmediastinalstaginginlungcancerbemeasured |